NCT02143986View on ClinicalTrials.gov

Glycosylated Ferritin in Macrophagic Activation Syndromes

RecruitingOBSERVATIONAL

Enrollment

60

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2030

Conditions

Still's Disease, Adult-OnsetSepsisMacrophagic Activation Syndrome

Trial Locations (1)

1020

RECRUITING

Brugmann University Hospital, Brussels

All Listed Sponsors

collaborator

Université Libre de Bruxelles

OTHER

lead

Brugmann University Hospital

OTHER